Medical Device News Magazine

Alveo’s Portable, Rapid Molecular Diagnostic Platform Proves Unshakable in Rigorous Ruggedness Tests

Neither a one-meter drop nor constant motion and vibration prevent the device from completing tests with near 100% accuracy, proving its utility at Point of Need™ in virtually any environment

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary technology platform, today announced the results of rigorous testing that demonstrate the ruggedness of its portable molecular testing platform. Whether it fell from a significant height, endured temperature and humidity extremes, or was subjected to jarring vibrations that mimic vehicle transportation of virtually any type — the device continued to complete tests and produce accurate results.

Alveo’s rapid molecular diagnostic platform has been designed to provide accurate, rapid test results at the point of need. The company tested its platform to demonstrate that it can perform reliably in harsh, real-world conditions, where markets, applications and use cases previously did not exist due to this unmet market need and requirement.

  • Specifically, the Alveo platform underwent the following tests:
    Environmental resilience: The device was placed in controlled chambers at 5 degrees Celsius and 40 degrees Celsius at up to 95% humidity for 24 hours.
    Movement and vibration: At a third-party facility, the platform was subjected to constant motion and vibration for nearly four hours (233 minutes and 34 seconds), simulating what the device would experience in the back of a moving delivery truck.
  • Drop testing: The device was dropped from up to 1 meter in height onto a hardwood board.
  • Cleaning: The analyzer was wiped down 100s of times with five different common disinfectants, including commercial bleach, isopropyl alcohol and hydrogen peroxide.

The results demonstrate that the Alveo platform can accurately perform tests in the field, under the most extreme of conditions. In the environmental resilience, drop, and cleaning tests, the device completed tests with 100% accuracy, and in the movement and vibration test, it also performed at 100% accuracy when the LED was facing up. When the LED was facing down during the vibration and movement test, it completed tests with 94% accuracy. The company is actively working on its next generation platform, enabling 360-degree capability with 100% accuracy.

“These tests thoroughly demonstrate our platform’s ability to provide consistent performance at the point of need, whether testing takes place in fields, on farms and in animal pens, remote locations, disaster zones, and beyond,” said Shaun Holt, CEO at Alveo. “Our rugged design and innovative molecular detection technology make it possible for healthcare providers, veterinarians, growers, and public health officials to obtain rapid, accurate results at the point of need, enabling them to take immediate action to treat and contain diseases, bacteria, fungi, and other contaminants. Alveo is leading the way by delivering a system that works in harsh environments where fast, easy testing without compromise is needed most. This study verifies that we can produce PCR-like results for a whole new set of applications, use cases, and a much broader user base than traditional molecular diagnostic methods.”

For more information on how the Alveo platform performed during ruggedness testing, read the full report: Built for Point of Need™ Detection: Ruggedness Testing of the Alveo Analyzer

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”